These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7291284)

  • 21. Effects of lesions in the ventral noradrenergic bundle on behavior and response to psychotropic drugs in rats.
    Jerlicz M; Kostowski W; Bidzinski A; Hauptmann M
    Pharmacol Biochem Behav; 1978 Dec; 9(6):721-4. PubMed ID: 34172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain amino acids as affected by acute and chronic administration of chlorpromazine.
    Himwich WA; Davis JM
    Biol Psychiatry; 1972 Aug; 5(1):89-98. PubMed ID: 5042316
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral concomitants of regional changes in the brain's biogenic amines after apomorphine and amphetamine.
    Schwarting RK; Huston JP
    Pharmacol Biochem Behav; 1992 Apr; 41(4):675-82. PubMed ID: 1594634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
    Goldstein M; Anagnoste B; Battista AF; Ogawa M
    Pharmacol Ther B; 1976; 2(1):97-103. PubMed ID: 817335
    [No Abstract]   [Full Text] [Related]  

  • 25. [Participation of monoaminergic mechanisms and the striatum in the development of "petit mal" induced by corazole].
    Arushanian EB; Avakian RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1175-81. PubMed ID: 151468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of drug-induced changes in brain monoamines on aggression and motor behavior in mice.
    Kramarcy NR; Brown JW; Thurmond JB
    Eur J Pharmacol; 1984 Mar; 99(2-3):141-51. PubMed ID: 6203764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 1,2-benzisoxazole-3-acetamidoxime on central monoamine neurons in the rat.
    Karasawa T; Furukawa K; Yoshida K; Shimizu M
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2673-85. PubMed ID: 1017104
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 30. Dietary amino acid precursors: effects on central monoamines, aggression, and locomotor activity in the mouse.
    Thurmond JB; Kramarcy NR; Lasley SM; Brown JW
    Pharmacol Biochem Behav; 1980 Apr; 12(4):525-32. PubMed ID: 6104821
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of 7-hydroxygluacine on brain biogenic monoamines].
    Petkov VD; Grakhoska T; Konstantinova E; Petkov VV
    Farmakol Toksikol; 1985; 48(3):19-22. PubMed ID: 4029374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold.
    Onaya ; Hashizume K
    Neuroendocrinology; 1976; 20(1):47-58. PubMed ID: 180445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL; Grewaal DS; McGeer EG
    Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):324-42. PubMed ID: 303083
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa.
    Jung MJ; Hornsperger JM; Gerhart F; Wagner J
    Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155
    [No Abstract]   [Full Text] [Related]  

  • 39. [Further aspects of the mechanism of action of tranquilizing agents. The influence of chlorpromazine on free amino acids of the rat brain].
    Ciorbaru R; Stroescu V; Gane P; Gheorghiu P
    Stud Cercet Fiziol; 1966; 11(6):501-5. PubMed ID: 5964003
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
    Sekso M; Solter M; Banovac K; Vizner B; Petek M
    Acta Med Iugosl; 1977; 31(4):321-32. PubMed ID: 596235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.